{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:14:01Z","timestamp":1787505241441,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010954","name":"Qingdao National Laboratory for Marine Science and Technology","doi-asserted-by":"publisher","award":["2022ONLM030003-2"],"award-info":[{"award-number":["2022ONLM030003-2"]}],"id":[{"id":"10.13039\/501100010954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108805","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:55:54Z","timestamp":1753919754000},"page":"108805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of novel TLR2 antagonists as anti-inflammatory agents"],"prefix":"10.1016","volume":"164","author":[{"given":"Xuehang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108805_bb0005","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1093\/jimmunol\/191.9.4475","article-title":"Pillars article: approaching the asymptote? Evolution and revolution in immunology. Cold spring harb symp quant biol. 1989. 54: 1-13","volume":"191","author":"Janeway","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0010","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.131202998","article-title":"How the immune system works to protect the host from infection: a personal view","volume":"98","author":"Janeway","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.108805_bb0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/287795a0","article-title":"Mutations affecting segment number and polarity in Drosophila","volume":"287","author":"N\u00fcsslein-Volhard","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108805_bb0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.immunol.21.120601.141126","article-title":"Toll-like receptors","volume":"21","author":"Takeda","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.immuni.2008.07.007","article-title":"Structures of the toll-like receptor family and its ligand complexes","volume":"29","author":"Jin","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2025.108805_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","article-title":"The role of TLR2 in infection and immunity","volume":"3","author":"Oliveira-Nascimento","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0035","doi-asserted-by":"crossref","first-page":"13766","DOI":"10.1073\/pnas.250476497","article-title":"The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors","volume":"97","author":"Ozinsky","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.108805_bb0040","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.24159","article-title":"Toll-like receptor 2\/4 heterodimer mediates inflammatory injury in intracerebral hemorrhage","volume":"75","author":"Wang","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12988","article-title":"TLR10: insights, controversies and potential utility as a therapeutic target","volume":"93","author":"Su","year":"2021","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0050","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.4049\/jimmunol.172.7.4425","article-title":"Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans","volume":"172","author":"Quesniaux","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005601","article-title":"Lipoteichoic acid induces unique inflammatory responses when compared to other toll-like receptor 2 ligands","volume":"4","author":"Long","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2025.108805_bb0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.smim.2006.12.004","article-title":"TLR signaling","volume":"19","author":"Kawai","year":"2007","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0065","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00018-011-0864-6","article-title":"Exogenous or endogenous toll-like receptor ligands: which is the MVP in tumorigenesis?","volume":"69","author":"Yu","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bioorg.2025.108805_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/v14050999","article-title":"SARS-CoV-2 envelope (E) protein binds and activates TLR2 pathway: a novel molecular target for COVID-19 interventions","volume":"14","author":"Plan\u00e8s","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2025.108805_bb0075","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/art.20219","article-title":"Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis","volume":"50","author":"Iwahashi","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bioorg.2025.108805_bb0080","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/1529-0131(200010)43:10<2160::AID-ANR3>3.0.CO;2-T","article-title":"Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines","volume":"43","author":"Schrijver","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bioorg.2025.108805_bb0085","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1586\/1744666X.2.4.585","article-title":"Toll-like receptors: a new target in rheumatoid arthritis?","volume":"2","author":"Drexler","year":"2006","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1124\/pr.109.001073","article-title":"Therapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancer","volume":"61","author":"O\u2019Neill","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2025.108805_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102260","article-title":"A small molecule toll-like receptor antagonist rescues \u03b1-synuclein fibril pathology","volume":"298","author":"Chedid","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108805_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512464","article-title":"An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes","volume":"24","author":"Colleselli","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108805_bb0105","doi-asserted-by":"crossref","first-page":"12246","DOI":"10.1002\/anie.201204910","article-title":"Discovery of small-molecule inhibitors of the TLR1\/TLR2 complex","volume":"51","author":"Cheng","year":"2012","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bioorg.2025.108805_bb0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmech.2019.06.059","article-title":"Structure-activity relationship study and biological evaluation of SAC-garlic acid conjugates as novel anti-inflammatory agents","volume":"179","author":"Bi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108805_bb0115","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/cmdc.201300445","article-title":"Prospective virtual screening in a sparse data scenario: design of small-molecule TLR2 antagonists","volume":"9","author":"Murgueitio","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108805_bb0120","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/cmdc.202000060","article-title":"Biological characterization, mechanistic investigation and structure-activity relationships of chemically stable TLR2 antagonists","volume":"15","author":"Bermudez","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.108805_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105043","article-title":"Discovery of isoliquiritigenin analogues that reverse acute hepatitis by inhibiting macrophage polarization","volume":"114","author":"Yang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108805_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113687","article-title":"The novel small-molecule antagonist MMG-11 preferentially inhibits TLR2\/1 signaling","volume":"171","author":"Grabowski","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcp.2018.04.018","article-title":"Identification of a pyrogallol derivative as a potent and selective human TLR2 antagonist by structure-based virtual screening","volume":"154","author":"Grabowski","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108805_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28135041","article-title":"A review of biologically active oxime ethers","volume":"28","author":"Kosmalski","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108805_bb0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2165\/00003495-199346050-00008","article-title":"Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness","volume":"46","author":"Wilde","year":"1993","journal-title":"Drugs"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825006856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:41:07Z","timestamp":1757655667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825006856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"alternative-id":["S0045206825006856"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108805","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel TLR2 antagonists as anti-inflammatory agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108805"}}